A transgenic zebrafish line for in vivo visualisation of neutrophil myeloperoxidase

Kyle D Buchan1, Tomasz K Prajsnar1, Nikolay V Ogryzko1,2

  • 1The Bateson Centre and Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Western Bank, Sheffield, United Kingdom.

Plos One
|April 20, 2019
PubMed

Insights

Researchers developed a new zebrafish model to visualize myeloperoxidase (MPO) enzyme activity in neutrophils. This tool aids in studying MPO

Area of Science:

  • Immunology
  • Cell Biology
  • Genetics

Background:

  • Neutrophil myeloperoxidase (MPO) generates antimicrobial compounds like hypochlorous acid (HOCl), crucial for pathogen destruction and inflammation regulation.
  • MPO's precise role in infection prevention is unclear, though deficiency increases candidiasis risk. MPO dysregulation is linked to inflammatory diseases like atherosclerosis.
  • Understanding MPO localization within neutrophils is vital for elucidating its dual role in disease prevention and exacerbation.

Purpose of the Study:

  • To develop a novel in vivo tool for visualizing myeloperoxidase (MPO) activity and neutrophil granule dynamics.
  • To create a transgenic zebrafish line expressing human MPO fused to a fluorescent tag for tracking its subcellular localization.
  • To validate the utility of this new model for studying MPO function without disrupting neutrophil behavior.

Main Methods:

  • Generated a transgenic zebrafish line (Tg(lyz:Hsa.MPO-mEmerald,cmlc2:EGFP)sh496) using Tol2 transgenesis, expressing human MPO-mEmerald under the neutrophil-specific lyz promoter.
  • Confirmed transgene expression and observed MPO-mEmerald localization within neutrophil-like subcellular granules.
  • Utilized Spotless (mpxNL144) mutant zebrafish larvae to assess the impact of the MPO-mEmerald transgene on neutrophil migration to inflammatory sites.

Main Results:

  • Successfully established a transgenic zebrafish line expressing human MPO fused to a fluorescent marker (mEmerald) in neutrophils.
  • Observed MPO-mEmerald localized to subcellular granules within zebrafish neutrophils, mimicking human MPO localization.
  • Demonstrated that the MPO-mEmerald transgene does not impede neutrophil migration in zebrafish larvae with non-functional endogenous MPO.

Conclusions:

  • A new transgenic zebrafish line expressing functional human MPO allows for in vivo visualization of neutrophil granule dynamics.
  • This model provides a valuable tool for studying MPO processing, maturation, and function in neutrophil-related diseases without altering neutrophil behavior.
  • Further research using this model can enhance understanding of MPO's role in innate immunity and inflammatory conditions.

Related Concept Videos

Transgenic Organisms00:53

Transgenic Organisms

Overview
33.2K
Transgenic Plants02:50

Transgenic Plants

Recombinant DNA technology called transgenesis is often used to add a foreign gene or remove a detrimental gene from an organism. Such genetically modified organisms are called transgenic organisms.
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
8.5K
Equivalence: In Vitro and In Vivo Bioequivalence01:17

Equivalence: In Vitro and In Vivo Bioequivalence

Body:Bioequivalence studies are crucial in evaluating whether new drugs can match an approved one regarding pharmacological effects and clinical performance. These studies test if drugs, despite different dosage forms, share identical plasma concentration-time profiles. Three types of equivalence are central to these studies: chemical, pharmaceutical, and therapeutic. Chemical equivalence indicates that two or more drug products contain identical active ingredients in equal amounts.
220
Drug Product Performance: In Vitro–In Vivo Correlation01:20

Drug Product Performance: In Vitro–In Vivo Correlation

In pharmaceutical development, it's crucial to establish a predictive in vitro–in vivo correlation (IVIVC) for two or more formulations to gain a comprehensive understanding of release properties. IVIVC reduces the need for costly in vivo studies and facilitates the establishment of meaningful dissolution specifications with significant cost savings and decreased regulatory burden. Furthermore, a meaningful IVIVC should predict Cmax and AUC within 20%, aligning with FDA guidance while...
264
Inflammation01:38

Inflammation

Overview
61.9K
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
83.5K